These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4756819)

  • 21. Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects.
    Solomon HM; Schrogie JJ
    Metabolism; 1967 Nov; 16(11):1029-33. PubMed ID: 4168588
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excretion of tolbutamide metabolites in young and old subjects.
    Miller AK; Adir J; Vestal RE
    Eur J Clin Pharmacol; 1990; 38(5):523-4. PubMed ID: 2379540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diurnal variation in the effect of tolbutamide.
    Johnson BF; Chura C
    Am J Med Sci; 1974 Aug; 268(2):93-6. PubMed ID: 4472066
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolbutamide kinetics in cigarette smokers in the Indian population.
    Uppal R; Sharma PL; Prakash C; Gupta HR
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):82-4. PubMed ID: 3957496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
    Reidenberg MM; Vesell ES
    Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of oral tolbutamide in chronic alcoholics.
    Horowitz SH; Johnson BF
    Am J Med Sci; 1972 Nov; 264(5):395-400. PubMed ID: 4650130
    [No Abstract]   [Full Text] [Related]  

  • 28. [Binding of tolbutamide by cholestyramine in vitro and in vivo].
    Rosenstiel K; Dördelmann E; Berthold K; Bock KD
    Verh Dtsch Ges Inn Med; 1973; 79():1223-5. PubMed ID: 4790142
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased clearance of tolbutamide from the blood of asthmatic patients.
    Sotaniemi E; Arvela P; Huhti E
    Ann Allergy; 1971 Mar; 29(3):139-41. PubMed ID: 5155517
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].
    Schulz E; Brinkmann W
    Dtsch Med Wochenschr; 1968 Mar; 93(11):485-91. PubMed ID: 5638113
    [No Abstract]   [Full Text] [Related]  

  • 31. The metabolism of (ureyl-14C)tolbutamide in vitro and in vivo in man.
    Darby FJ; Grundy RK
    Life Sci; 1973 Jul; 13(2):97-105. PubMed ID: 4356419
    [No Abstract]   [Full Text] [Related]  

  • 32. Tolbutamide-sulfaphenazole interaction in rabbits.
    Shibasaki J; Konishi R; Yamasaki K
    J Pharmacokinet Biopharm; 1977 Jun; 5(3):277-90. PubMed ID: 881646
    [No Abstract]   [Full Text] [Related]  

  • 33. Carboxytolbutamide excretion following subcutaneous implantation of tolbutamide spheres in rats.
    BALLARD BE; NELSON E
    Arch Int Pharmacodyn Ther; 1961; 133():206-11. PubMed ID: 13864429
    [No Abstract]   [Full Text] [Related]  

  • 34. Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.
    Veronese ME; Miners JO; Randles D; Gregov D; Birkett DJ
    Clin Pharmacol Ther; 1990 Mar; 47(3):403-11. PubMed ID: 2311340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM; Miners JO
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences.
    Dogterom P; Rothuizen J
    Drug Metab Dispos; 1993; 21(4):705-9. PubMed ID: 8104131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive quantitative and qualitative liquid chromatography-radioisotope-mass spectrometry analysis for safety testing of tolbutamide metabolites without standard samples.
    Tozuka Z; Aoyama S; Nozawa K; Akita S; Oh-Hara T; Adachi Y; Ninomiya S
    J Pharm Sci; 2011 Sep; 100(9):4024-36. PubMed ID: 21638282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of drug metabolism by chloramphenicol.
    Christensen LK; Skovsted L
    Lancet; 1969 Dec; 2(7635):1397-9. PubMed ID: 4188280
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of the absorption rate of tolbutamide on the rate of decline of blood sugar levels in normal humans.
    NELSON E; KNOECHEL EL; HAMLIN WE; WAGNER JG
    J Pharm Sci; 1962 Jun; 51():509-14. PubMed ID: 14478904
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution of tolbutamide and chlorpropamide after administration to non-diabetic rats.
    Nistrup Madsen S; Fog-Moller F; Persson I
    Eur J Pharmacol; 1971; 13(3):374-80. PubMed ID: 5577500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.